DAGLUTRIL
DAGLUTRIL, SLV306 phase 2 Daglutril is a novel dual-action endopeptidase inhibitor which had been in phase II clinical development by Solvay for the treatment of hypertension, congestive heart failure...
View ArticleANDARINE, Male drugs
Andarine (SARM-4, S-4), GTx-007 Acetamidoxolutamide Androxolutamide 401900-40-1 WO 2002016310 Selective Androgen Receptor Modulators (SARM) Signal Transduction Modulators Andarine (GTx-007, S-4)...
View ArticlePortola gets FDA breakthrough therapy status for andexanet alfa
andexanet alfa Portola gets FDA breakthrough therapy status for andexanet alfa US-based biopharmaceutical firm Portola Pharmaceuticals has received breakthrough therapy designation from the US Food...
View ArticleGW Pharmaceuticals obtains Swiss approval for Sativex
Nabiximols Combination of Tetrahydrocannabinol Cannabinoid Cannabidiol Cannabinoid GW Pharmaceuticals obtains Swiss approval for Sativex GW Pharmaceuticals has received full marketing authorisation...
View ArticlePRANLUKAST
PRANLUKAST Antiasthmatic. Launched – 1995 japan150821-03-7, C27 H23 N5 O4 . H2O, 499.5179 103177-37-3 anhydrous, 103180-28-5 (monosodium salt) Ono-1078 Ono-RS-411 RS-411 SB-205312 Ono-1070 (monosodium...
View ArticleConatus’s liver drug emricasan gets FDA orphan drug status
254750-02-2 cas no emricasan PF 03491390, IDN 6556 pfizer Prevention of fibrosis and inflammation in chronic liver disease The compound had been studied in phase II clinical trials for the treatment...
View ArticleDRUG SPOTLIGHT …TRANDOLAPRIL
TRANDOLAPRIL (2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid 87679-37-6 CAS NO C24-H34-N2-O5, 430.549 Indications. hypertention...
View ArticleEuropean Commission approves Fluenz Tetra for the prevention of seasonal...
Friday, 6 December 2013 AstraZeneca today announced that the European Commission (EC) has granted Marketing Authorisation to FluenzTM Tetra. Fluenz Tetra is a nasally administered four-strain live...
View ArticleUS Approves Breakthrough Hepatitis C Drug, Sofosbuvir
WASHINGTON, Dec. 6, 2013 (AP) — Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to...
View ArticleTandospirone
Tandospirone CAS.87760-53-0, (3aa,4b,7b,7aa)-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione Additional Names:...
View ArticlePITAVASTATIN
PITAVASTATIN, LIVALO, Itavastatin calcium, Nisvastatin, NKS-104, NK-104, (3R, 5S) -7 – [2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl] -3,5-dihydroxy-6 (E)-heptenoic acid calcium salt (2:1) CAS...
View ArticleALISKIREN
(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide, 173334-57-1, base 173334-58-2,aliskiren...
View ArticleTOFOGLIFLOZIN
TOFOGLIFLOZIN CSG-452 R-7201 RG-7201 CAS..1201913-82-7 903565-83-3 (anhydrous)...
View ArticleREMOGLIFLOZIN
REMOGLIFLOZIN ETABONATE 5-methyl-4-[4-(1-methylethoxy)benzyl]-1-(1-methylethyl)-1H-pyrazol-3-yl 6-O-(ethoxycarbonyl)-β-D-glucopyranoside, CAS 442201-24-3 189075 BHV-091009 GSK-189075 GSK-189075A...
View ArticleLUSEOGLIFLOZIN
LUSEOGLIFLOZIN, CAS 898537-18-3 An antidiabetic agent that inhibits sodium-dependent glucose cotransporter 2 (SGLT2). Taisho (Originator), PHASE 3 TS-071 WO 2010119990 WO2006073197 TS-071, an SGLT-2...
View ArticleA Drug Against Obesity?
Small synthetic molecule identified that ameliorates obesity-related disorders in animal models Read more A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity, Miki...
View ArticleERTUGLIFLOZIN
ERTUGLIFLOZIN, PFIZER THERAPEUTIC CLAIM Treatment of type 2 diabetes CHEMICAL NAMES 1. β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)- 2....
View ArticleICOTINIB
ICOTINIB N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine [1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine,...
View ArticlePITAVASTATIN
PITAVASTATIN, LIVALO, Itavastatin calcium, Nisvastatin, NKS-104, NK-104, (3R, 5S) -7 – [2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl] -3,5-dihydroxy-6 (E)-heptenoic acid calcium salt (2:1) CAS...
View ArticleRIGOSERTIB
Rigosertib (E)-2-(2-Methoxy-5-(2-(2′,4′,6′-trimethoxyphenyl)vinylsulfonamido)phenylamino)acetic Acid THERAPEUTIC CLAIM Antineoplastic CHEMICAL NAMES 1. Glycine,...
View Article